Sionix Corporation (OTCBB:SINX) reached up 25.38% in morning trading to $.163 with 1M shares traded. Sionix designs innovative, advanced and mobile water treatment systems. These systems can be used to remove organic and inorganic compounds, including infectious bacteria from contaminated water. They are also used as pre-treatment for desalination and other membrane filtration applications. Any industry that uses water in the manufacture of their products or delivery of their services can benefit from the cost-effective, easily maintained, portable water treatment systems provided by Sionix. Sionix Corporation (OTC.BB:SINX - News) ("Sionix") today reported successful independent third-party testing results for its Mobile Water Treatment System (MWTS). The Sionix MWTS removed contaminants of the same, or substantially similar, atomic weight and structure as the radioactive isotopes of those same elements currently found in Japan's water supply, contaminants in produced and frac water faced by oil and gas drillers, and contaminants in wastewater and runoff resulting from agricultural activity.
Sterling Chemicals (PINK:SCHI) reached up 59.48% in morning trading to $2.44 with 300K shares traded. Sterling Chemicals, Inc. is a North American producer of selected petrochemicals. They are headquartered in Houston, Texas, and they manufacture all of their petrochemicals at their Texas City, Texas, facility. Sterling Chemicals (Other OTC:SCHI.PK) announced today that it has entered into a definitive merger agreement pursuant to which Eastman Chemical (EMN) will acquire all of the outstanding equity of Sterling Chemicals for $100M in cash, subject to certain adjustments as provided in the merger agreement.
Fibrocell Science, Inc. (OTCBB:FCSC) reached up 10.34% in morning trading to $1.28 with 8M shares traded. Fibrocell Science, Inc. is a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. Fibrocell Science, Inc. (OTCBB:FCSC.OB.ob - News) announced today that the U.S. Food and Drug Administration (FDA) approved the Company’s Biologics License Application for its lead product, laVív® (azficel-T) late last night. laVív is the first and only personalized aesthetic cell therapy approved by the FDA for the improvement of the appearance of moderate to severe nasolabial fold wrinkles (smile lines) in adults. In clinical trials, laVív was well tolerated with the majority of adverse events being injection-site reactions that were of mild to moderate intensity and resolved within one week.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
